February 5, 2019
Via: Mass DeviceCellect Biotechnology (NSDQ:APOP) said it is collaborating with Washington University on a study of its ApoGraft stem cell selection technology for bone marrow transplantations. This will be the first clinical trial in the U.S. using Tel Aviv, Israel-based Cellect’s ApoGraft, […]
November 30, 2023
November 28, 2023
November 21, 2023
November 16, 2023
November 14, 2023
November 7, 2023
November 10, 2023